Dapagliflozin modulates diabetic kidney disease through indirect transcriptional regulation rather than direct transcriptional reversal.
Аннотация
BACKGROUND
Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide. While sodium-glucose co-transporter 2 inhibitors (SGLT2i) confer remarkable renoprotection, the molecular mechanisms underlying their efficacy remain incompletely understood.
METHODS
We performed an integrative cross-species transcriptomic analysis comparing dapagliflozin-modulated signatures in diabetic mice with human DKD pathophysiology. Public RNA-sequencing datasets were analyzed: GSE142025 (human kidney biopsies: advanced DKD n = 21, early DKD n = 6, controls n = 9) and GSE228727 (diabetic db/db mice ± dapagliflozin).
RESULTS
Advanced human DKD exhibited 2145 dysregulated genes (False Discovery Rate [FDR] < 0.05) enriched in fibrosis and inflammation pathways. In contrast, dapagliflozin induced a focused 13-gene signature (11 downregulated, 2 upregulated). Matched-cohort analysis revealed minimal overlap between drug and disease signatures: only 7 dapagliflozin-downregulated genes were among diabetes-upregulated genes (hypergeometric P = .542). Gene Set Enrichment Analysis confirmed no global transcriptional reversal (normalized enrichment score [NES] = -1.04, FDR q = 0.86). Despite this limited overlap, unsupervised clustering using the 13-gene signature robustly stratified human patients by disease state.
CONCLUSION
SGLT2 inhibitors do not reverse disease transcriptional programs but operate through indirect modulation of a focused gene signature largely independent of primary disease drivers. This signature provides prioritized candidates for mechanistic investigation and biomarker development in DKD.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.